Francis D’Hondt

MIAMI — The pharmaceutical industry has long been considered a laggard in digital advertising innovation, hamstrung by regulatory hurdles and lengthy compliance approvals. But that gap is finally closing as programmatic capabilities mature and creative strategies become more sophisticated. The shift represents a fundamental change in how pharma marketers approach campaigns, moving away from siloed […]